Established Technology Trials, Comparative Studies Sought By HHS Panel
This article was originally published in The Gray Sheet
Executive Summary
NIH should involve multiple device manufacturers in "proof-of-principle" trials only when technologies have become established, according to National Heart, Lung & Blood Institute's Michael Domanski, MD